Case of Hereditary Papillary Renal Cell Carcinoma Type I in a Patient With a Germline MET Mutation in Russia
Hereditary papillary renal carcinoma (HPRC) is a rare autosomal dominant disease characterized by the development of multiple papillary type I renal cell carcinomas. This hereditary kidney cancer form is caused by activating mutations in MET. Descriptions of patients with HPRC are scarce in the worl...
Main Authors: | Dmitry S. Mikhaylenko, Alexey V. Klimov, Vsevolod B. Matveev, Svetlana I. Samoylova, Vladimir V. Strelnikov, Dmitry V. Zaletaev, Ludmila N. Lubchenko, Boris Y. Alekseev, Marina V. Nemtsova |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01566/full |
Similar Items
-
Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis
by: Dmitry S. Mikhaylenko, et al.
Published: (2020-01-01) -
Roles of E-cadherin and Noncoding RNAs in the Epithelial–mesenchymal Transition and Progression in Gastric Cancer
by: Irina V. Bure, et al.
Published: (2019-06-01) -
Epigenetic Changes in the Pathogenesis of Rheumatoid Arthritis
by: Marina V. Nemtsova, et al.
Published: (2019-06-01) -
A rare germline mutation c.2752 A>G (p.M918V) in the RET protooncogene in a patient with medullary and papillary thyroid carcinomas in cervical lymph node metastases: a case report and review of the literature
by: Faina A. Amosenko, et al.
Published: (2016-06-01) -
Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
by: Klara Johansson, et al.
Published: (2021-08-01)